Ligand profile
CZ6
Ligand co-crystallized with this exact protein (Protein Data Bank).
Bound to: KP13_32248 — Beta-lactamase SHV-12
Identifiers
Database identifiers and provenance.
- Ligand ID
CZ6- PDB
3mke- UniProt (this protein)
P0AD64- Target protein
- KP13_32248
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 145.4
- −1 ≤ LogP ≤ 5 1.06
- MW ≤ 500 Da 412.3
- LogP ≤ 5 1.06
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 9
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 145.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
B1(O[C@H](CC(O1)(C)C)C)CNC(=O)/C(=N\OC(C)(C)C(=O)O)/c2csc(n2)NB1(O[C@H](CC(O1)(C)C)C)CNC(=O)/C(=N\OC(C)(C)C(=O)O)/c2csc(n2)N
InChI=1S/C16H25BN4O6S/c1-9-6-15(2,3)26-17(25-9)8-19-12(22)11(10-7-28-14(18)20-10)21-27-16(4,5)13(23)24/h7,9H,6,8H2,1-5H3,(H2,18,20)(H,19,22)(H,23,24)/b21-11-/t9-/m0/s1InChI=1S/C16H25BN4O6S/c1-9-6-15(2,3)26-17(25-9)8-19-12(22)11(10-7-28-14(18)20-10)21-27-16(4,5)13(23)24/h7,9H,6,8H2,1-5H3,(H2,18,20)(H,19,22)(H,23,24)/b21-11-/t9-/m0/s1
VUZFEPQBACFWNR-GAGKSFBISA-NVUZFEPQBACFWNR-GAGKSFBISA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF00144' 'PF13354
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CZ6 →
- PDB RCSB structure 3mke →
- UniProt UniProt P0AD64 (same protein) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CZ6”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_32248.
PDB 43
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).